Teladoc Health, Inc. (TDOC)

5.06 -0.1 (-1.94%)

As of 2026-03-03 12:09:17 EST

Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company headquartered in New York, New York, United States that was founded in 2002. Primary services include telehealth, medical opinions, AI and analytics, telehealth devices and licensable platform services. In particular, Teladoc Health uses telephone and videoconferencing software as well as mobile apps to provide on-demand remote medical care.

Traded asNYSE: TDOC
ISINUS87918A1051
CIK0001477449
LEI549300I2PVFBC9MFAC61
EIN043705970
SectorMedical care
IndustryServices-Offices & Clinics of Doctors of Medicine
CEOChuck Divita, III
Employees5,500
Fiscal Year End1231
Address155 E 44TH STREET, NEW YORK, NY, 10017
Phone2036352002
Websitehttp://teladochealth.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
TDOCTeladoc Health, Inc.2026-03-03 12:09:175.06-0.1-1.94
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
TDOC0001477449Teladoc Health, Inc.US87918A1051549300I2PVFBC9MFAC61043705970NYSE8011Services-Offices & Clinics of Doctors of Medicine1231DE155 E 44TH STREETNEW YORKNY10017UNITED STATESUS2036352002155 E 44TH STREET, NEW YORK, NY, 10017155 E 44TH STREET, NEW YORK, NY, 10017Teladoc, Inc.Medical care2002Chuck Divita, III5,500http://teladochealth.com1,531,762,802178,315,400178,396,434Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company headquartered in New York, New York, United States that was founded in 2002. Primary services include telehealth, medical opinions, AI and analytics, telehealth devices and licensable platform services. In particular, Teladoc Health uses telephone and videoconferencing software as well as mobile apps to provide on-demand remote medical care.2026-02-26 18:13:21
This is a preview of the latest data. Subscribe to access the full data.
TDOC Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
TDOC Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
20251,531,762,802-134,308,902-8.0614178,396,4344,724,4022.7203
20241,666,071,704-2,478,568,464-59.8018173,672,0326,633,0663.971
20234,144,640,168-1,189,394,842-22.2982167,038,9664,421,7742.7191
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Adam C. VandervoortChief Legal Officer, Secretary2024466,66794,0001,929,852130,00013,8002,634,319
Kelly BlissPresident2024467,84190,6001,752,498190,00013,8002,514,739
Charles DivitaChief Executive Officer2024450,000015,028,180448,087135,00016,061,267
Mala MurthyChief Financial Officer2024566,25204,430,642220,00013,8005,230,694
Carlos NuenoPresident2024502,21497,5271,643,530410,87884,9892,739,138
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
20255,600
20245,500
20235,600
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue2,529,977,0002,569,574,0002,602,415,000
Cost Of Revenue771,593,000751,270,000760,031,000
Gross Profit———
Research And Development Expenses277,922,000307,274,000348,521,000
General And Administrative Expenses431,891,000435,490,000464,659,000
Operating Expenses2,792,932,0003,590,460,0002,850,968,000
Operating Income-262,955,000-1,020,886,000-248,553,000
Net Income-200,322,000-1,001,245,000-220,368,000
Earnings Per Share Basic-1.14-5.87-1.34
Earnings Per Share Diluted-1.14-5.87-1.34
Weighted Average Shares Outstanding Basic176,221,530170,564,088164,578,219
Weighted Average Shares Outstanding Diluted176,221,530170,564,088164,578,219
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents781,084,0001,298,327,0001,123,675,000
Marketable Securities Current———
Accounts Receivable192,826,000214,146,000217,423,000
Inventories38,203,00038,138,00029,513,000
Non Trade Receivables———
Other Assets Current2,071,0002,828,0007,443,000
Total Assets Current1,119,129,0001,663,907,0001,489,048,000
Marketable Securities Non Current———
Property Plant And Equipment26,972,00029,487,00032,032,000
Other Assets Non Current105,803,00081,488,00080,258,000
Total Assets Non Current26,972,00029,487,00032,032,000
Total Assets2,858,300,0003,516,524,0004,392,369,000
Accounts Payable47,967,00033,130,00043,637,000
Deferred Revenue62,305,00079,296,00095,659,000
Short Term Debt———
Other Liabilities Current22,942,00027,427,00033,691,000
Total Liabilities Current404,738,000941,535,000420,616,000
Long Term Debt994,925,000991,418,0001,538,688,000
Other Liabilities Non Current643,000720,0001,080,000
Total Liabilities Non Current1,067,856,0001,083,910,000—
Total Liabilities1,472,594,0002,025,445,000—
Common Stock178,000173,000167,000
Retained Earnings-16,430,222,000-16,229,900,000-15,228,655,000
Accumulated Other Comprehensive Income-34,728,000-38,388,000-36,990,000
Total Shareholders Equity1,385,706,0001,491,079,0002,326,073,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization———
Share Based Compensation Expense80,414,000145,951,000201,550,000
Other Non Cash Income Expense-6,399,000-9,796,000310,000
Change In Accounts Receivable-25,126,000375,00010,252,000
Change In Inventories-399,0009,749,000-24,095,000
Change In Non Trade Receivables———
Change In Other Assets-7,997,0001,257,00023,052,000
Change In Accounts Payable11,454,000-10,365,000-4,185,000
Change In Other Liabilities———
Cash From Operating Activities294,357,000293,680,000350,021,000
Purchases Of Marketable Securities27,875,000——
Sales Of Marketable Securities—00
Acquisition Of Property Plant And Equipment8,893,00010,790,00011,464,000
Acquisition Of Business81,904,000—0
Other Investing Activities-60,0000-1,000
Cash From Investing Activities-266,003,000-124,052,000-156,347,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock3,000,000——
Repurchase Of Common Stock———
Issuance Of Long Term Debt———
Repayment Of Long Term Debt———
Other Financing Activities0-2,0000
Cash From Financing Activities-551,652,0008,312,00010,854,000
Change In Cash-523,298,000177,940,000204,528,000
Cash At End Of Period781,084,0001,298,327,0001,123,675,000
Income Taxes Paid8,745,0008,946,0007,238,000
Interest Paid15,008,00017,322,00017,422,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share-1.14-5.87-1.34
Price To Earnings Ratio-6.1404-1.5486-16.0821
Earnings Growth Rate-80.5792338.0597-98.4161
Price Earnings To Growth Ratio0.0762-0.00460.1634
Book Value Per Share7.86348.74224.1329
Price To Book Ratio0.89021.03980.893
Ebitda———
Enterprise Value1,447,391,7101,243,518,559.923,961,673,619.45
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.7180.66490.6615
Capital Expenditures———
Free Cash Flow———
Return On Equity-0.1446-0.6715-0.0947
One Year Beta1.3911.47282.2992
Three Year Beta1.62091.94361.9197
Five Year Beta1.73071.01341.0506
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Smith Michael SDirector2026-02-1853,648A53,648
Catapano Joseph RonaldChief Accounting Officer2026-01-05758D6,686
Catapano Joseph RonaldChief Accounting Officer2026-01-022,083A7,444
Catapano Joseph RonaldChief Accounting Officer2026-01-022,083D14,584
Evans Jason EricDirector2025-12-191,016A9,145
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Donald Sternoff Beyer2020-05-12VA08Sale2020-04-27Joint$1,001 - $15,000
Bradley S. Schneider2018-07-15IL10Purchase2017-06-04Spouse$15,001 - $50,000
Bradley S. Schneider2018-06-10IL10Purchase2018-05-04Spouse$100,001 - $250,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Qube Research & Technologies Ltd2025-12-3179,80011,4007
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.2025-12-311,205,190172,1707
TWO SIGMA INVESTMENTS, LP2025-12-314,742,885677,5557
Creative Planning2025-12-31141,72420,2467.0001
BANCO BILBAO VIZCAYA ARGENTARIA, S.A.2025-12-31950,718136,8216.9486
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
PIMCO Equity Series2025-12-31Class APMJAX2,354,59716,482,1790.5483
PIMCO Equity Series2025-12-31I-2PMJPX2,354,59716,482,1790.5483
PIMCO Equity Series2025-12-31Institutional ClassPMJIX2,354,59716,482,1790.5483
PIMCO Equity Series2025-12-31PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETFMFUS2,74519,2150.0091
Advisor Managed Portfolios2025-12-31Optimize Strategy Index ETFOPTZ55,115385,8050.1926
This is a preview of the latest data. Subscribe to access the full data.